Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

Six years after his Alzheimer’s diagnosis, 90-year-old Zelik Bocknek (Zel) refuses to slow down — and he believes his active ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Fortunately, the FDA has approved antipsychotic treatments that help manage these destructive symptoms, and more are in ...

Research involving the UAB reveals the most effective way to talk to people with Alzheimer's so that their emotional response ...

"We are excited to have completed administering first doses to all patients enrolled in our phase 2 Alzheimer's trial,” stated RJ Tesi PhD, the CEO of INmune Bio. "A global trial of this size is a ...

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

The onset of symptoms of Alzheimer's disease can occur and worsen faster in people that also have an alcohol use disorder ...

Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.

The drug developed by U.S. pharmaceutical giant Eli Lilly and Co. will be offered to patients experiencing dementia and ...

New research from Scripps Research links Alzheimer’s disease and alcohol use disorder, showing similar gene expression ...